Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

HVO

Hvivo (HVO)

Hvivo Plc
De:
Trier par:
 Showing the most relevant articles for your search:LSE:HVO
DateHeureSourceTitreSymboleSociété
08/01/202408h00UK RegulatoryhVIVO PLC Broker changeLSE:HVOHvivo Plc
02/01/202411h16Alliance NewsAlliance NewshVIVO inks GBP6.3 million deal to test common cold treatmentLSE:HVOHvivo Plc
02/01/202408h00UK RegulatoryhVIVO PLC GBP6.3m HRV contract signed with biotech clientLSE:HVOHvivo Plc
13/12/202312h44Alliance NewsAlliance NewshVIVO signs deal to test RSV antiviral drug candidate with study modelLSE:HVOHvivo Plc
13/12/202308h00UK RegulatoryhVIVO PLC GBP16.8m RSV contract & Trading ahead of guidanceLSE:HVOHvivo Plc
05/10/202312h45Alliance NewsAlliance NewshVIVO celebrates positive results for Pneumagen's Neumifil in trialLSE:HVOHvivo Plc
05/10/202308h00RNS Non-RegulatoryhVIVO PLC Positive results from flu human challenge studyLSE:HVOHvivo Plc
12/09/202312h33Alliance NewsAlliance NewshVIVO interim profit jumps on revenue increase; ups full-year guidanceLSE:HVOHvivo Plc
12/09/202308h00UK RegulatoryhVIVO PLC Interim resultsLSE:HVOHvivo Plc
01/09/202308h00UK RegulatoryhVIVO PLC Exercise of WarrantsLSE:HVOHvivo Plc
29/08/202312h32Alliance NewsAlliance NewshVIVO announces plans for new Canary Wharf facility as demand growsLSE:HVOHvivo Plc
29/08/202308h00UK RegulatoryhVIVO PLC Plans for a new larger state-of-the-art facilityLSE:HVOHvivo Plc
24/08/202308h00UK RegulatoryhVIVO PLC Notice of ResultsLSE:HVOHvivo Plc
26/07/202315h29Alliance NewsAlliance NewsIN BRIEF: hVIVO interim revenue grows; in line with expectationsLSE:HVOHvivo Plc
26/07/202308h00UK RegulatoryhVIVO PLC Trading updateLSE:HVOHvivo Plc
25/07/202315h25Alliance NewsAlliance NewshVIVO secures GBP13.1 million contract for influenza B modelLSE:HVOHvivo Plc
25/07/202308h00UK RegulatoryhVIVO PLC Flu B challenge modelLSE:HVOHvivo Plc
28/06/202315h16Alliance NewsAlliance NewshVIVO inks deal to manufacture human hMPV virus for challenge trialLSE:HVOHvivo Plc
28/06/202308h00UK RegulatoryhVIVO PLC hMPV human challenge modelLSE:HVOHvivo Plc
14/06/202309h00UK RegulatoryhVIVO PLC Director dealingsLSE:HVOHvivo Plc
02/06/202322h42Alliance NewsAlliance NewsIN THE KNOW: hVIVO involvement in drug approval should boost interestLSE:HVOHvivo Plc
23/05/202313h36UK RegulatoryhVIVO PLC Result of AGMLSE:HVOHvivo Plc
28/04/202308h00UK RegulatoryhVIVO PLC Annual Report and Notice of AGMLSE:HVOHvivo Plc
26/04/202316h44Alliance NewsAlliance NewsTRADING UPDATES: Skillcast swings to loss, RM Infrastructure NAV downLSE:HVOHvivo Plc
26/04/202308h00RNS Non-RegulatoryhVIVO PLC FDA Breakthrough and Fast Track for US biotechLSE:HVOHvivo Plc
25/04/202315h39Alliance NewsAlliance NewsEARNINGS SUMMARY: hVIVO sees 30% revenue growth; Next 15 lifts payoutLSE:HVOHvivo Plc
25/04/202308h00UK RegulatoryhVIVO PLC Final resultsLSE:HVOHvivo Plc
06/04/202316h54UK RegulatoryhVIVO PLC Holding(s) in CompanyLSE:HVOHvivo Plc
03/04/202313h13Alliance NewsAlliance NewshVIVO touts positive test results from seasonal flu drug, CD388LSE:HVOHvivo Plc
29/03/202308h00RNS Non-RegulatoryhVIVO PLC Presentation at World Vaccine CongressLSE:HVOHvivo Plc
 Showing the most relevant articles for your search:LSE:HVO